Allosteric properties of G protein-coupled receptor oligomers

Pharmacology and Therapeutics

Volumn 115, Issue 3, 2007, Pages 410-418

  Springael, Jean Yves ^a   Urizar, Eneko ^a   Costagliola, Sabine ^a   Vassart, Gilbert ^a   Parmentier, Marc ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Allostery; Binding cooperativity; Dimerization; GPCR

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ADRENOMEDULLIN; ALPHA 2 ADRENERGIC RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; DIMER; DOPAMINE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FOLLITROPIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; LEUKOTRIENE B4 RECEPTOR; LUTEINIZING HORMONE RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; OLIGOMER; OPIATE RECEPTOR; QUISQUALIC ACID; THYROTROPIN; THYROTROPIN RECEPTOR;

ALLOSTERISM; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; COMPLEX FORMATION; DIMERIZATION; DRUG RECEPTOR BINDING; GENE OVEREXPRESSION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 34548398610     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2007.06.004     Document Type: Review

References (93)

1. Agnati L.F., Tarakanov A.O., and Guidolin D. A simple mathematical model of cooperativity in receptor mosaics based on the "symmetry rule". Biosystems 80 (2005) 165-173
2. Albizu L., Balestre M.N., Breton C., Pin J.P., Manning M., Mouillac B., et al. Probing the existence of G protein-coupled receptor dimers by positive and negative ligand-dependent cooperative binding. Mol Pharmacol 70 (2006) 1783-1791
3. Angers S., Salahpour A., Joly E., Hilairet S., Chelsky D., Dennis M., et al. Detection of beta(2)-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci U S A 97 (2000) 3684-3689
4. Angers S., Salahpour A., and Bouvier M. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 42 (2002) 409-435
5. Baneres J.L., and Parello J. Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B-4 receptor BLT1 and the G-protein. J Mol Biol 329 (2003) 815-829
6. Bayburt T.H., Leitz A.J., Xie G., Oprian D.D., and Sligar S.G. Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins. J Biol Chem 282 (2007) 14875-14881
7. Binet V., Brajon C., Le Corre L., Acher F., Pin J.P., and Prezeau L. The heptahelical domain of GABA(B2) is activated directly by CGP7930, a positive allosteric modulator of the GABA(B) receptor. J Biol Chem 279 (2004) 29085-29091
8. Bockaert J., and Pin J.P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18 (1999) 1723-1729
9. Bockaert J., Fagni L., Dumuis A., and Marin P. GPCR interacting proteins (GIP). Pharmacol Ther 103 (2004) 203-221
10. Bouvier M., Heveker N., Jockers R., Marullo S., and Milligan G. BRET analysis of GPCR oligomerization: newer does not mean better. Nat Methods 4 (2007) 3-4
11. Breit A., Gagnidze K., Devi L.A., Lagace M., and Bouvier M. Simultaneous activation of the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling. Mol Pharmacol 70 (2006) 686-696
12. Breitwieser G.E. G protein-coupled receptor oligomerization- implications for G protein activation and cell signaling. Circ Res 94 (2004) 17-27
13. Bulenger S., Marullo S., and Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci 26 (2005) 131-137
14. Chen C., Li J., Bot G., Szabo I., Rogers T.J., and Liu-Chen L.Y. Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. Eur J Pharmacol 483 (2004) 175-186
15. Christopoulos A., and Kenakin T. G protein-coupled receptor allosterism and complexing. Pharmacol Rev 54 (2002) 323-374
16. Damian M., Martin A., Mesnier D., Pin J.P., and Baneres J.L. Asymmetric conformational changes in a GPCR dimer controlled by G-proteins. EMBO J 25 (2006) 5693-5702
17. Davis M.E., Akera T., Brody T.M., and Watson L. Opiate receptor: cooperativity of binding observed in brain slices. Proc Natl Acad Sci U S A 74 (1977) 5764-5766
18. De Lean A., Stadel J.M., and Lefkowitz R.J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem 255 (1980) 7108-7117
19. de Meyts P. Cooperative properties of hormone receptors in cell membranes. J Supramol Struct 4 (1976) 241-258
20. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia growth and development study, multicenter AIDS cohort study, multicenter Hemophilia cohort study, San Francisco City Cohort, ALIVE Study. Science 273 (1996) 1856-1862
21. Dean M.K., Higgs C., Smith R.E., Bywater R.P., Snell C.R., Scott P.D., et al. Dimerization of G-Protein-coupled receptors. J Med Chem 44 (2001) 4595-4614
22. Durroux T. Principles: a model for the allosteric interactions between ligand binding sites within a dimeric GPCR. Trends Pharmacol Sci 26 7 (2005) 376-384
23. El Asmar L., Springael J.Y., Ballet S., Andrieu E.U., Vassart G., and Parmentier M. Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol Pharmacol 67 (2005) 460-469
24. Filipek S., Krzysko K.A., Fotiadis D., Liang Y., Saperstein D.A., Engel A., et al. A concept for G protein activation by G protein-coupled receptor dimers: the transducin/rhodopsin interface. Photochem Photobiol Sci 3 (2004) 628-638
25. Filizola M., and Weinstein H. The study of G-protein coupled receptor oligomerization with computational modeling and bioinformatics. FEBS J 272 (2005) 2926-2938
26. Fotiadis D., Liang Y., Filipek S., Saperstein D.A., Engel A., and Palczewski K. Atomic-force microscopy: rhodopsin dimers in native disc membranes. Nature 421 (2003) 127-128
27. Franco R., Casado V., Mallol J., Ferrada C., Ferre S., Fuxe K., et al. The two-state dimer receptor model: a general model for receptor dimers. Mol Pharmacol 69 (2006) 1905-1912
28. Galvez T., Duthey B., Kniazeff J., Blahos J., Rovelli G., Bettler B., et al. Allosteric interactions between GB1 and GB2 subunits are required for optimal GABA(B) receptor function. EMBO J 20 (2001) 2152-2159
29. George S.R., Fan T., Xie Z.D., Tse R., Tam V., Varghese G., et al. Oligomerization of mu- and delta-opioid receptors- generation of novel functional properties. J Biol Chem 275 (2000) 26128-26135
30. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21 (2000) 90-113
31. Gomes I., Jordan B.A., Gupta A., Trapaidze N., Nagy V., and Devi L.A. Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J Neurosci 20 (2000) [art-RC110]
32. Gomes I., Gupta A., Filipovska J., Szeto H.H., Pintar J.E., and Devi L.A. A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 101 (2004) 5135-5139
33. Gouldson P.R., Snell C.R., Bywater R.P., Higgs C., and Reynolds C.A. Domain swapping in G-protein coupled receptor dimers. Protein Eng 11 (1998) 1181-1193
34. Guo W., Shi L., and Javitch J.A. The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. J Biol Chem 278 (2003) 4385-4388
35. Guo W., Shi L., Filizola M., Weinstein H., and Javitch J.A. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc Natl Acad Sci U S A 102 (2005) 17495-17500
36. +, and amiloride analogs. J Biol Chem 265 (1990) 17307-17317
37. Hay D.L., Conner A.C., Howitt S.G., Smith D.M., and Poyner D.R. The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors. J Mol Neurosci 22 (2003) 105-113
38. Hay D.L., Poyner D.R., and Sexton P.M. GPCR modulation by RAMPS. Pharmacol Ther 109 (2006) 173-197
39. Hlavackova V., Goudet C., Kniazeff J., Zikova A., Maurel D., Vol C., et al. Evidence for a single heptahelical domain being turned on upon activation of a dimeric GPCR. EMBO J 24 (2005) 499-509
40. Holst B., Elling C.E., and Schwartz T.W. Metal ion-mediated agonism and agonist enhancement in melanocortin MC1 and MC4 receptors. J Biol Chem 277 (2002) 47662-47670
41. James J.R., Oliveira M.I., Carmo A.M., Iaboni A., and Davis S.J. A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer. Nat Methods 3 (2006) 1001-1006
42. Jastrzebska B., Fotiadis D., Jang G.F., Stenkamp R.E., Engel A., and Palczewski K. Functional and structural characterization of rhodopsin oligomers. J Biol Chem 281 (2006) 11917-11922
43. Johnson Z., Power C.A., Weiss C., Rintelen F., Ji H., Ruckle T., et al. Chemokine inhibition-why, when, where, which and how?. Biochem Soc Trans 32 (2004) 366-377
44. Jones K.A., Borowsky B., Tamm J.A., Craig D.A., Durkin M.M., Dai M., et al. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 396 (1998) 674-679
45. Jordan B.A., and Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399 (1999) 697-700
46. Jordan B.A., Trapaidze N., Gomes I., Nivarthi R., and Devi L.A. Oligomerization of opioid receptors with beta(2)-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci U S A 98 (2001) 343-348
47. Kaupmann K., Malitschek B., Schuler V., Heid J., Froestl W., Beck P., et al. GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396 (1998) 683-687
48. Kenakin T. Receptor conformational induction versus selection: all part of the same energy landscape. Trends Pharmacol Sci 17 (1996) 190-191
49. Kenakin T., Jenkinson S., and Watson C. Determining the potency and molecular mechanism of action of insurmountable antagonists. J Pharmacol Exp Ther 319 (2006) 710-723
50. Kniazeff J., Bessis A.S., Maurel D., Ansanay H., Prezeau L., and Pin J.P. Closed state of both binding domains of homodimeric MGlu receptors is required for full activity. Nat Struct Mol Biol 11 (2004) 706-713
51. Kraft K., Olbrich H., Majoul I., Mack M., Proudfoot A., and Oppermann M. Characterization of sequence determinants within the carboxyl-terminal domain of chemokine receptor CCR5 that regulate signaling and receptor internalization. J Biol Chem 276 (2001) 34408-34418
52. Kuhn H., Bennett N., Michel-Villaz M., and Chabre M. Interactions between photoexcited rhodopsin and GTP-binding protein: kinetic and stoichiometric analyses from light-scattering changes. Proc Natl Acad Sci U S A 78 (1981) 6873-6877
53. Kuner R., Kohr G., Grunewald S., Eisenhardt G., Bach A., and Kornau H.C. Role of heteromer formation in GABAB receptor function. Science 283 (1999) 74-77
54. Langmead C.J., and Christopoulos A. Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox. Trends Pharmacol Sci 27 (2006) 475-481
55. Levitzki A. Negative co-operativity in clustered receptors as a possible basis for membrane action. J Theor Biol 44 (1974) 367-372
56. Liang Y., Fotiadis D., Filipek S., Saperstein D.A., Palczewski K., and Engel A. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J Biol Chem 278 (2003) 21655-21662
57. Limbird L., de Meyts P., and Lefkowitz R.J. Beta-adrenergic receptors: evidence for negative cooperativity. Biochem Biophys Res Commun 64 (1975) 1160-1168
58. Maggio R., Vogel Z., and Wess J. Reconstitution of functional muscarinic receptors by coexpression of amino-terminal and carboxyl-terminal receptor fragments. FEBS Lett 319 (1993) 195-200
59. Maggio R., Novi F., Scarselli M., and Corsini G.U. The impact of G-protein-coupled receptor hetero-oligomerization on function and pharmacology. FEBS J 272 (2005) 2939-2946
60. Mallee J.J., Salvatore C.A., LeBourdelles B., Oliver K.R., Longmore J., Koblan K.S., et al. Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists. J Biol Chem 277 (2002) 14294-14298
61. Mattera R., Pitts B.J., Entman M.L., and Birnbaumer L. Guanine nucleotide regulation of a mammalian myocardial muscarinic receptor system. Evidence for homo- and heterotropic cooperativity in ligand binding analyzed by computer-assisted curve fitting. J Biol Chem 260 (1985) 7410-7421
62. May L.T., Sexton P.M., Ijzerman A.P., and Christopoulos A. Divergent mechanisms for allosteric modulators of adenosine A1 receptors. FASEB J 20 (2006) A1119
63. Mcvey M., Ramsay D., Kellett E., Rees S., Wilson S., Pope A.J., et al. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer-the human delta-opioid receptor displays constitutive oligomerization at the cell surface, which is not regulated by receptor occupancy. J Biol Chem 276 (2001) 14092-14099
64. Mercier J.F., Salahpour A., Angers S., Breit A., and Bouvier M. Quantitative assessment of beta(1)- and beta(2)-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem 277 (2002) 44925-44931
65. Mesnier D., and Baneres J.L. Cooperative conformational changes in a G-protein-coupled receptor dimer, the leukotriene B(4) receptor BLT1. J Biol Chem 279 (2004) 49664-49670
66. Meyer B.H., Segura J.M., Martinez K.L., Hovius R., George N., Johnsson K., et al. FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells. Proc Natl Acad Sci U S A 103 (2006) 2138-2143
67. Milligan G., Ramsay D., Pascal G., and Carrillo J.J. GPCR dimerisation. Life Sci 74 (2003) 181-188
68. Monnot C., Bihoreau C., Conchon S., Curnow K.M., Corvol P., and Clauser E. Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling-reconstitution of the binding site by co-expression of two deficient mutants. J Biol Chem 271 (1996) 1507-1513
69. Murphy P.M. International union of pharmacology: XXX. Update on chemokine receptor nomenclature. Pharmacol Rev 54 (2002) 227-229
70. Murphy P.M., Baggiolini M., Charo I.F., Hebert C.A., Horuk R., Matsushima K., et al. International union of pharmacology: XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52 (2000) 145-176
71. Nelson G., Hoon M.A., Chandrashekar J., Zhang Y.F., Ryba N.J.P., and Zuker C.S. Mammalian sweet taste receptors. Cell 106 (2001) 381-390
72. Nelson G., Chandrashekar J., Hoon M.A., Feng L.X., Zhao G., Ryba N.J.P., et al. An amino-acid taste receptor. Nature 416 (2002) 199-202
73. Neve K.A. Regulation of dopamine D2 receptors by sodium and PH. Mol Pharmacol 39 (1991) 570-578
74. Novi F., Stanasila L., Giorgi F., Corsini G.U., Cotecchia S., and Maggio R. Paired activation of two components within muscarinic M-3 receptor dimers is required for recruitment of beta-arrestin-1 to the plasma membrane. J Biol Chem 280 (2005) 19768-19776
75. Ott S., Costa T., and Herz A. Sodium modulates opioid receptors through a membrane component different from G-proteins. Demonstration by target size analysis. J Biol Chem 263 (1988) 10524-10533
76. Pin J.P., Galvez T., and Prezeau L. Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. Pharmacol Ther 98 (2003) 325-354
77. Powell-Jones C.H., Thomas Jr. C.G., and Nayfeh S.N. Contribution of negative cooperativity to the thyrotropin-receptor interaction in normal human thyroid: kinetic evaluation. Proc Natl Acad Sci U S A 76 (1979) 705-709
78. Prinster S.C., Hague C., and Hall R.A. Heterodimerization of G protein-coupled receptors: specificity and functional significance. Pharmacol Rev 57 (2005) 289-298
79. Reggio P.H. Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers. AAPS J 8 (2006) E322-E336
80. Schwartz T.W., and Holst B. Ago-allosteric modulation and other types of allostery in dimeric 7TM receptors. J Recept Signal Transduct Res 26 (2006) 107-128
81. Soudijn W., Van W.I., and Ijzerman A.P. Allosteric modulation of G protein-coupled receptors: perspectives and recent developments. Drug Discov Today 9 (2004) 752-758
82. Springael J.Y., Urizar E., and Parmentier M. Dimerization of chemokine receptors and its functional consequences. Cytokines & Growth Factor Review 16 (2005) 611-623
83. Springael J.Y., Le Minh P.N., Urizar E., Costagliola S., Vassart G., and Parmentier M. Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers. Mol Pharmacol 69 (2006) 1652-1661
84. Staudinger R., Wang X., and Bandres J.C. Allosteric regulation of CCR5 by guanine nucleotides and HIV-1 envelope. Biochem Biophys Res Commun 286 (2001) 41-47
85. Suzuki S., Chuang L.F., Yau P., Doi R.H., and Chuang R.Y. Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with ccr5 on immune cells. Exp Cell Res 280 (2002) 192-200
86. Suzuki Y., Moriyoshi E., Tsuchiya D., and Jingami H. Negative cooperativity of glutamate binding in the dimeric metabotropic glutamate receptor subtype 1. J Biol Chem 279 (2004) 35526-35534
87. Terrillon S., and Bouvier M. Roles of G-protein-coupled receptor dimerization- from ontogeny to signalling regulation. EMBO Rep 5 (2004) 30-34
88. Tucek S., and Proska J. Allosteric modulation of muscarinic acetylcholine-receptors. Trends Pharmacol Sci 16 (1995) 205-212
89. Urizar E., Montanelli L., Loy T., Bonomi M., Swillens S., Gales C., et al. Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J 24 (2005) 1954-1964
90. Urwyler S., Mosbacher J., Lingenhoehl K., Heid J., Hofstetter K., Froestl W., et al. Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol Pharmacol 60 (2001) 963-971
91. White J.H., Wise A., Main M.J., Green A., Fraser N.J., Disney G.H., et al. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 396 (1998) 679-682
92. Whorton M.R., Bokoch M.P., Rasmussen S.G., Huang B., Zare R.N., Kobilka B., et al. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc Natl Acad Sci U S A 104 (2007) 7682-7687
93. Wreggett K.A., and Wells J.W. Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors. J Biol Chem 270 (1995) 22488-22499